Missouri legislation · 2026 Regular Session
Missouri HB3357: Prohibits the sale of intravenous solution containers and intravenous tubing products intentionally made with DEHP
Status: In committee, May 15, 2026
What the bill says
To amend chapter 191, RSMo, by adding thereto one new section relating to the safety of medical devices. Section A. Chapter 191, RSMo, is amended by adding thereto one new section, to be known as section 191.647, to read as follows: 191.647. 1. As used in this section, the following terms (2) "Intentionally added DEHP", DEHP that a manufacturer has intentionally added to a product and that has a functional or technical effect on the product; (3) "Intravenous solution container", a container used to house medicine, fluid, or nutrition therapy that is intravenously delivered to a patient in a ho.
From the introduced text:
To amend chapter 191, RSMo, by adding thereto one new section relating to the safety of medical devices. Section A. Chapter 191, RSMo, is amended by adding thereto one new section, to be known as section 191.647, to read as follows: 191.647. 1. As used in this section, the following terms (2) "Intentionally added DEHP", DEHP that a manufacturer has intentionally added to a product and that has a functional or technical effect on the product; (3) "Intravenous solution container", a container used to house medicine, fluid, or nutrition therapy that is intravenously delivered to a patient in a hospital, outpatient facility, or other health care facility; (4) "Intravenous tubing", tubing used to intravenously administer fluids, medication, or nutrients directly to an adult, child, or infant; (5) "Ortho-phthalate", a class of chemicals that are esters of ortho-phthalic acid, including DEHP or any of the (b) Dibutyl phthalate (DBP); (c) Dicyclohexyl phthalate (DCHP); (d) Diethyl phthalate (DEP); (e) Diisobutyl phthalate (DIBP); (f) Diisodecyl phthalate (DIDP); EXPLANATION -- Matter enclosed in bold-faced brackets [thus] in the above bill is not enacted and is intended to be omitted from the law. Matter in bold-face type in the above bill is proposed language. HB 3357 (g) Diisononyl phthalate (DINP); (h) Di-n-hexyl phthalate (DnHP); (i) Di-n-octyl phthalate (DNOP); (j) Di-n-pentyl phthalate (DnPP); or (k) Diisoheptyl …